Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial

Robert P. Frantz, Vallerie V. McLaughlin, Sandeep Sahay, Pilar Escribano Subías, Ronald Zolty, Raymond L. Benza, Richard N. Channick, Kelly Chin, Anna R. Hemnes, Luke Howard, Olivier Sitbon, Jean‐Luc Vachiéry, Roham T. Zamanian, Matt Cravets, Robert F. Roscigno, David Mottola, Robin Osterhout, Jean‐Marie Bruey, Erin Elman, Cindy‐ann Tompkins, Ed Parsley, Richard Aranda, Lawrence S. Zisman, Hossein-Ardeschir Ghofrani, Yochai Adir, T. Baillie, David Baratz, Charles Burger, Murali M. Chakinala, Jose Ales Martinez, Marion Delcroix, Nathan Dwyer, Jean Elwing, Micah R. Fisher, Verónica Franco, Ekkehard Grünig, Kristin B. Highland, Nicholas S. Hill, Naushad Hirani, Marius M. Hoeper, Pavel Jansa, Anne Keogh, J.F. Kingrey, Manuel López‐Meseguer, John W. McConnell, Sanjay Mehta, Lana Melendres‐Groves, Christian Opitz, Joanna Pepke‐Żaba, Priya Pillutla, Franck Rahaghi, Amresh Raina, Yael Raviv, Jeffrey C. Robinson, John Ryan, Jeffrey S. Sager, Shelley Shapiro, Marc A. Simon, Kerri Smith, I. Sobol, Namita Sood, Leslie Spikes, Stefan Stadler, Wendy B.C. Stevens, Roxana Sulica, R. James White